Product Information
AMINOCAPROIC ACID 0.25 GRAM/ML is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.5736 per ML under NDC 69680011408. Its NADAC has been published 75 times since Apr 30, 2025.
FDA first approved this application on Dec 27, 2023. Its Orange Book therapeutic-equivalence code is AA.
Strength
.25 g/mL
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680011408
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMINOCAPROIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA213213FDA Approved
12/27/2023
TE Code
AA
On Market Since
7/19/2024
Pharmacological Classes
Price Statistics
The NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has been published 75 times since Apr 30, 2025, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5736 per ML |
|---|---|
| All-time high | $1.0525 (Aug 13, 2025) |
| All-time low | $0.5736 (Sep 23, 2026) |
| 52-week high | $1.0256 |
| 52-week low | $0.5736 |
| Median price | $0.7749 |
| Average price | $0.8364 |
| Largest weekly change | -11.2% (Jul 22, 2026) |
| Weeks tracked | 75 |
| Tracking since | Apr 30, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Vitruvias Therapeutics Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aminocaproic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMINOCAPROIC ACID 0.25 GRAM/ML?
The current National Average Drug Acquisition Cost (NADAC) for AMINOCAPROIC ACID 0.25 GRAM/ML, manufactured by Vitruvias Therapeutics Inc., is $0.5736 per ML (NDC 69680011408), effective Sep 30, 2026.
How has the price of AMINOCAPROIC ACID 0.25 GRAM/ML changed over time?
Over the history we have for it, the NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has declined 42.1%. It has been tracked across 75 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for AMINOCAPROIC ACID 0.25 GRAM/ML?
Since Apr 30, 2025, the NADAC for AMINOCAPROIC ACID 0.25 GRAM/ML has ranged from a low of $0.5736 (Sep 23, 2026) to a high of $1.0525 (Aug 13, 2025), with a median of $0.7749 per ML.
Are there cheaper alternatives to AMINOCAPROIC ACID 0.25 GRAM/ML?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMINOCAPROIC ACID 0.25 GRAM/ML in a comparable dosage form, but none are currently priced below it.
Who manufactures AMINOCAPROIC ACID 0.25 GRAM/ML?
AMINOCAPROIC ACID 0.25 GRAM/ML (NDC 69680011408) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.